Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study

Mohan, M., Monge, J., Shah, N., Luan, D., Forsberg, M., Bhatlapenumarthi, V., Balev, M., Patwari, A., Cheruvalath, H., Bhutani, D., Thanendrarajan, S., Dhakal, B., Zangari, M., Al-Hadidi, S., Cooper, D., Lentzsch, S., van Rhee, F., D’Souza, A., Szabo, A., … Chakraborty, R. (2024). Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood Cancer Journal, 14(1). https://doi.org/10.1038/s41408-024-01003-z
Authors:
Meera Mohan
Vineel Bhatlapenumarthi
Anannya Patwari
Binod Dhakal
Anita D'Souza
Jorge Monge
Danny Luan
Nishi Shah
Mark Forsberg
Dennis Cooper
Metodi Balev
Divaya Bhutani
Suzanne Lentzsch
Rajshekhar Chakraborty
Heloise Cheruvalath
Sharmilan Thanendrarajan
Maurizio Zangari
Samer Al-Hadidi
Carolina Schinke
Frits van Rhee
Aniko Szabo
Affiliated Authors:
Metodi Balev
Divaya Bhutani
Suzanne Lentzsch
Rajshekhar Chakraborty
Columbia Affiliation:
Related Items:
Conference Proceeding
Mohan, M., Shah, N., Luan, D., Monge, J., Forsberg, M., Bhatlapenumarthi, V., Balev, M., Patwari, A., Cheruvalath, H., Bhutani, D., Thanendrarajan, S., Dhakal, B., Zangari, M., Al Hadidi, S., Cooper, D. L., Lentzsch, S., van Rhee, F., D’Souza, A., Szabo, A., … Chakraborty, R. (2023). Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study. Blood, 142(Supplement 1), 545–545. https://doi.org/10.1182/blood-2023-174875
Publication Date
View
OpenAlex Record
elink
Publication Type:
Article
Unique ID:
10.1038/s41408-024-01003-z
PMID:
38443345
DOI:
10.1038/s41408-024-01003-z
Journal:
Blood Cancer Journal
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record
View Scopus Record

Record Created: